[HTML][HTML] Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)

MJ Ali - Progress in Retinal and Eye Research, 2023 - Elsevier
Primary acquired nasolacrimal duct obstruction, or PANDO, is a common adult lacrimal
drainage disorder. The current treatment modality of dacryocystorhinostomy to bypass the …

Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy

RE Ruiz-Lozano, NS Azar, HM Mousa… - Frontiers in …, 2023 - frontiersin.org
Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and
the corneal and conjunctival epithelium, is a well-known complication of topical glaucoma …

Effects of Topical Anti-Glaucoma Medications on Outcomes of Endoscopic Dacryocystorhinostomy: Comparison with Age-and Sex-Matched Controls

SE Lee, HB Lim, S Oh, K Lee, SB Lee - Journal of Clinical Medicine, 2024 - mdpi.com
Background: This study analyzed the effects of topical anti-glaucoma medications on the
surgical outcomes of endoscopic dacryocystorhinostomy (EDCR) in nasolacrimal duct …

Outcomes of Endoscopic Endonasal Dacryocystorhinostomy in Glaucoma Patients

GM Pace, F Giombi, G Muci, G Giunta, F Pirola… - Journal of Personalized …, 2024 - mdpi.com
Background: Anti-glaucoma eye drops have been investigated due to their production of
fibrotic changes on the conjunctival surface, undermining the functioning of the upper …

[PDF][PDF] Endoscopic endonasal dacryocystorhinostomy: is assuming topical anti-glaucoma medications a contraindication?

GM Pace, F Giombi, G Muci, G Giunta, F Pirola… - 2023 - scholar.archive.org
Purpose Topical anti-glaucoma medications have been investigated on producing brotic
changes on the conjunctival surface, undermining the functioning of the upper lacrimal …